Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FDC Bromopride and Simethicone in Functional Dyspepsia
NCT02604576Phase 3Completed
- Sponsor
- EMS
- Start
- Jan 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of simethicone in functional dyspepsia (FD), sponsored by EMS. Started Jan 2017; status: completed.
02
Drugs
simethicone
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT02604576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02604576.